Bio-Techne Corporation TECH NASDAQ

Bio-Techne Corporation (TECH) generated $287.56M in operating cash flow for fiscal year 2025. After capital expenditures of $31.01M, free cash flow was $256.55M.

Free cash flow margin was 21% of revenue. Cash conversion ratio was 3.92x, indicating earnings are backed by cash.

The company returned $50.39M in dividends and $275.73M in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
• MOAT (65/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (45/100) — Cash conversion ratio was 3.92x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 64/100 with 3/7 criteria passed.